Life Image has announced the launch of its new Real World Imaging (RWI) offering, with the aim of responding to researcher needs for maturing insights and accelerating drug development decisions. With its digital platform that is powered by industry-leading interoperability standards, according to a press release, Life Image specialises in “living” or evolving datasets of novel imaging that’s linkable to other clinical information. Life Image’s RWI will also be used to train artificial intelligence (AI) models demanding deeper accuracy and sensitivity across diverse datasets.
The press release reports that the RWI “living” datasets represent hundreds of thousands of patients, tens of millions of images and hundreds of thousands of associated reports and studies categorised by more than 25 anatomical parts including head, lung, breast, chest and more. This heterogeneous and continuously growing data represents an expanding variety of demographics, temporal data, linked longitudinal records and virtually every global manufacturer across all modalities. It adds that, since 2008, Life Image has been the market leader using common interoperability standards to solve the many technical, procedural and structural barriers that have effectively segregated imaging data into unconnected data silos.
Matthew A Michela, CEO and president, Life Image, comments: “The time has finally arrived that imaging can be used as an effective part of the real-world evidence process by eliminating manual processing and compliance errors, providing access to large heterogeneous data sets, and doing so at the speed of the internet. With RWI, Life Image is expanding its focus on helping researchers and innovators capture the full potential of RWE by providing ‘living’ data sets that grow and become even more meaningful over time. This makes it possible to answer questions as they arise as opposed to answering one question in a limited manner retrospectively, such as carefully controlled clinical trials. The potential benefits are innumerable for patients, payers, population health initiatives, artificial intelligence, and drug and device development.”
In addition to RWI data, Life Image also provides value-added services to researchers and innovators including end-to-end management for de-identification, data curation and linking across medical claims, EHR, genetics and other phenotypical commercial and public data assets.
